Cargando…

Self-Mixed/Split Insulin Regimen: A Serious Omission in the ADA/EASD Position Statement

Detalles Bibliográficos
Autor principal:	Davidson, Mayer B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868001/ https://www.ncbi.nlm.nih.gov/pubmed/24356589 http://dx.doi.org/10.2337/dc13-1665

Ejemplares similares

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Inzucchi, Silvio E., et al.
Publicado: (2012)

Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
por: Ibrahim, Mahmoud, et al.
Publicado: (2020)

Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy – A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults
por: Fritsche, Andreas
Publicado: (2023)

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Inzucchi, SE, et al.
Publicado: (2013)

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
por: Schernthaner, G., et al.
Publicado: (2010)

Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
por: Schernthaner, G., et al.
Publicado: (2010)

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Chung, Wendy K., et al.
Publicado: (2020)

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021)

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations
por: Bae, Jay P., et al.
Publicado: (2022)

Correlates of Insulin Injection Omission
por: Peyrot, Mark, et al.
Publicado: (2010)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Rodbard, Helena W., et al.
Publicado: (2012)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Giaccari, Andrea, et al.
Publicado: (2012)

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2018)

Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021)

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2022)

Highlights vom EASD 2022
por: Stiefelhagen, Peter
Publicado: (2022)

Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Matthews, David R., et al.
Publicado: (2012)

The changing landscape of scientific communication at EASD
por: Mathieu, Chantal, et al.
Publicado: (2022)

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2016)

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2018)

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2019)

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Buse, John B., et al.
Publicado: (2020)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

The Genome Russia project: closing the largest remaining omission on the world Genome map
por: Oleksyk, Taras K., et al.
Publicado: (2015)

NSAIDs and self-medication: A serious concern
por: Doomra, Reena, et al.
Publicado: (2020)

Abstracts of 52nd EASD Annual Meeting
Publicado: (2016)

Abstracts of the 49th Annual Meeting of the EASD
Publicado: (2013)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Evidence Synthesis International (ESI): Position Statement
por: Gough, David, et al.
Publicado: (2020)

Omission
Publicado: (1881)

An Omission
Publicado: (1885)

Omission
Publicado: (1867)

Omission
Publicado: (1882)

An Omission
Publicado: (1875)

Omission
Publicado: (1858)

Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement
por: Rodacki, M., et al.
Publicado: (2021)

Position Statement on Breastfeeding from the Italian Pediatric Societies
por: Davanzo, Riccardo, et al.
Publicado: (2015)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ija34qdtgup629q7s7k3vgapp4